{
    "elements": [
        {
            "type": "image",
            "sequence_num": 1,
            "data": {
                "url": "MSEPO-21077 Research management policy.001.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 2,
            "data": {
                "num_rows": 16,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Title:"
                    },
                    {
                        "text": "RESEARCH MANAGEMENT POLICY"
                    },
                    {
                        "text": "Document Reference/ Register no:"
                    },
                    {
                        "text": "MSEPO-21077"
                    },
                    {
                        "text": "Version Number:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Document type: (Policy/ Guideline/ SOP/CCP)"
                    },
                    {
                        "text": "Policy"
                    },
                    {
                        "text": "To be followed by: (Target Staff)"
                    },
                    {
                        "text": "All research active staff"
                    },
                    {
                        "text": "Ratification Issue Date: (Date document is uploaded onto the intranet)"
                    },
                    {
                        "text": "29 April 2021"
                    },
                    {
                        "text": "Review Date:"
                    },
                    {
                        "text": "28 April 2024"
                    },
                    {
                        "text": "Key word(s) to search for document on intranet and internet:"
                    },
                    {
                        "text": "Research, management"
                    },
                    {
                        "text": "Developed in response to: (National Guidance/Recommendations (i.e. NICE; RCOG)"
                    },
                    {
                        "text": "UK policy framework for health and social care research 2017 Medicines for Human Use (Clinical Trials) (2004) Regulations Good Clinical Practice"
                    },
                    {
                        "text": "Contributes to HSC Act 2008 (Regulated Activities) Regulations 2014(Part 3); and CQC Regulations 2009 (Part 4) CQC Fundamental Standards of Quality and Safety:"
                    },
                    {
                        "text": "12, 17"
                    },
                    {
                        "text": "Issuing Division/Directorate:"
                    },
                    {
                        "text": "Corporate"
                    },
                    {
                        "text": "Author/Contact: (Asset Administrator)"
                    },
                    {
                        "text": "Ashley Solieri"
                    },
                    {
                        "text": "Group Head of Research"
                    },
                    {
                        "text": "Hospital Sites: (tick appropriate box(s) to indicate status of policy review i.e. joint/ independent)"
                    },
                    {
                        "text": "\u2612 MSE NHS Foundation Trust \u2610 Basildon Hospital \u2610 Broomfield Hospital \u2610 Southend Hospital \u2610 Other (please state)"
                    },
                    {
                        "text": "Approval Group / Committee(s):"
                    },
                    {
                        "text": "MSEFT Research and Development Committee"
                    },
                    {
                        "text": "19 April 2021"
                    },
                    {
                        "text": "Professionally Approved by: (Asset Owner)"
                    },
                    {
                        "text": "David Walker"
                    },
                    {
                        "text": "Chief Medical Officer"
                    },
                    {
                        "text": "19 April 2021"
                    },
                    {
                        "text": "Consultation:"
                    },
                    {
                        "text": "(Refer to page 2)"
                    },
                    {
                        "text": "Ratification Group(s):"
                    },
                    {
                        "text": "Joint Document Management Group"
                    },
                    {
                        "text": "27 April 2021"
                    },
                    {
                        "text": "Executive and Clinical Directors (Communication of minutes from Joint Document Management Group)"
                    },
                    {
                        "text": "May 2021"
                    },
                    {
                        "text": "Distribution Method:"
                    },
                    {
                        "text": "\u2612 Trust Intranet"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "image",
            "sequence_num": 3,
            "data": {
                "url": "MSEPO-21077 Research management policy.002.png"
            }
        },
        {
            "type": "table",
            "sequence_num": 4,
            "data": {
                "num_rows": 4,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Consulted With: (Must include Specialist Pharmacists if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "Emma Chaplin"
                    },
                    {
                        "text": "Clinical Trial Pharmacist"
                    },
                    {
                        "text": "19 March 2021"
                    },
                    {
                        "text": "Matt Barker"
                    },
                    {
                        "text": "Head of Information Governance & Data Protection"
                    },
                    {
                        "text": "08 April 2021"
                    },
                    {
                        "text": "Dr Sarah Mapplebeck"
                    },
                    {
                        "text": "Consultant Clinical Biochemist"
                    },
                    {
                        "text": "15 April 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 5,
            "data": {
                "num_rows": 2,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Post/ Approval Committee/ Group: (Must include Medication Assurance Group if the document has any reference to medication)"
                    },
                    {
                        "text": "Date:"
                    },
                    {
                        "text": "MSEFT Research and Development Committee"
                    },
                    {
                        "text": "19 April 2021"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 6,
            "data": {
                "num_rows": 2,
                "num_cols": 1,
                "table_items": [
                    {
                        "text": "Related Trust Policies (to be read in conjunction with)"
                    },
                    {
                        "text": "(Refer to the main body of the text) Commercial income distribution policy or equivalent, Intellectual property policy or equivalent, Information governance and management policy or equivalent, MSEFT National data opt out policy or equivalent, MSEFT Health and safety management policy or equivalent, MSEFT Whistleblowing policy or equivalent, MSEFT Workforce investigation policy or equivalent, MSEFT Conduct and capability policy or equivalent, MSEFT Grievance and disputes policy or equivalent, MSEFT Pharmacy clinical trial SOPs or equivalent, MSEFT research standard operating procedures, or equivalent"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 7,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Document Review History:"
                    },
                    {
                        "text": "Version No:"
                    },
                    {
                        "text": "Authored/Reviewer:"
                    },
                    {
                        "text": "Summary of amendments/ Record documents superseded by:"
                    },
                    {
                        "text": "Issue Date:"
                    },
                    {
                        "text": "1.0"
                    },
                    {
                        "text": "Ashley Solieri"
                    },
                    {
                        "text": "New MSE policy: supersedes the following documents: Basildon Hospital: CP/PO/00143 Incorporated research fraud and misconduct policy; COPO00136 BTUH UK policies framework for health and social care policies; Broomfield Hospital: 04052 Research and development operational management policy; Southend Hospital: RA01 Research and development management policy."
                    },
                    {
                        "text": "29 April 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Contents"
            },
            "type": "ListItem",
            "sequence_num": 8
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "Introduction ................................................................................................................... 5"
            },
            "type": "ListItem",
            "sequence_num": 9
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "Scope ........................................................................................................................... 7"
            },
            "type": "ListItem",
            "sequence_num": 10
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 3.0,
                "text": "Definitions ..................................................................................................................... 7"
            },
            "type": "ListItem",
            "sequence_num": 11
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Role and responsibilities within MSEFT ...................................................................... 10"
            },
            "type": "ListItem",
            "sequence_num": 12
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Confirming capability and capacity for research projects ............................................ 12"
            },
            "type": "ListItem",
            "sequence_num": 13
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Ethical practice ........................................................................................................... 14"
            },
            "type": "ListItem",
            "sequence_num": 14
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Study progress and performance management .......................................................... 15"
            },
            "type": "ListItem",
            "sequence_num": 15
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Financial management ............................................................................................... 16"
            },
            "type": "ListItem",
            "sequence_num": 16
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "Data protection ........................................................................................................... 16  Good clinical practice training (GCP) .......................................................................... 17  Contracts and agreements ......................................................................................... 17  Research personnel .................................................................................................... 18  Peer review ................................................................................................................. 19  Fraud and misconduct in research.............................................................................. 19  Involving consumers in research ................................................................................ 21  Intellectual property (IP) rights .................................................................................... 21  Publication of research ............................................................................................... 21  Training requirements ................................................................................................. 22  Monitoring and audit ................................................................................................... 22  Approval and implementation ..................................................................................... 23  Equality impact assessment ....................................................................................... 23  References ................................................................................................................. 23 Appendix 1: Principles that apply to all health and social care research ............................ 28 Appendix 2: Responsibilities framework ............................................................................ 28"
            },
            "type": "ListItem",
            "sequence_num": 17
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appendix 3: Preliminary equality analysis .......................................................................... 35"
            },
            "type": "ListItem",
            "sequence_num": 18
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 1.0,
                "text": "Introduction"
            },
            "type": "ListItem",
            "sequence_num": 19
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.1,
                "text": "This policy supports the national ambition to make the UK a great place to do research where more people have the opportunity to participate in health and social care research and continue to feel safe when they do."
            },
            "type": "ListItem",
            "sequence_num": 20
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.2,
                "text": "The Policy enhances the ability of Mid and South Essex Hospital NHS Foundation Trust (MSEFT) to deliver its vision to be recognised as a centre of research excellence because:"
            },
            "type": "ListItem",
            "sequence_num": 21
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patient care is enhanced by MSEFT being research-active,"
            },
            "type": "ListItem",
            "sequence_num": 22
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Research supports the strategic and operational needs of the organisation, and"
            },
            "type": "ListItem",
            "sequence_num": 23
        },
        {
            "data": {
                "is_heading": 0,
                "text": "MSEFT and its staff are recognised as being an exemplar for the conduct of research."
            },
            "type": "ListItem",
            "sequence_num": 24
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.3,
                "text": "MSEFT is committed, and has put in place a structure (Figure 1) and processes, to develop and support an environment where:"
            },
            "type": "ListItem",
            "sequence_num": 25
        },
        {
            "data": {
                "is_heading": 0,
                "text": "a) Patients, service users and the public are given, and take, the opportunity to participate in health and social care research, and are confident about doing so; new treatments, care and other services are developed through ethical and scientifically sound research for the benefit of patients, service users and the public;"
            },
            "type": "ListItem",
            "sequence_num": 26
        },
        {
            "data": {
                "is_heading": 0,
                "text": "b) Applying to do research is simple and getting a decision is quick and predictable;"
            },
            "type": "ListItem",
            "sequence_num": 27
        },
        {
            "data": {
                "is_heading": 0,
                "text": "c) Researchers find it straightforward to do high-quality, ethical research; commissioners and providers of health and social care appreciate how health and social care research benefits patients, service users, staff and the public;"
            },
            "type": "ListItem",
            "sequence_num": 28
        },
        {
            "data": {
                "is_heading": 0,
                "text": "d) Industry sees MSEFT as a great place to do health and social care research;"
            },
            "type": "ListItem",
            "sequence_num": 29
        },
        {
            "data": {
                "is_heading": 0,
                "text": "e) Money from charities and other research funders goes into carrying out research, not into navigating needless bureaucracy or duplicating previous work; and"
            },
            "type": "ListItem",
            "sequence_num": 30
        },
        {
            "data": {
                "is_heading": 0,
                "text": "f) Research projects are registered, the data and tissue they collect can be made available for future analysis, where appropriate and with adequate consent and safeguards,"
            },
            "type": "ListItem",
            "sequence_num": 31
        },
        {
            "data": {
                "is_heading": 0,
                "text": "g) And research findings are published in academic journals and summarised for those who took part in them."
            },
            "type": "ListItem",
            "sequence_num": 32
        },
        {
            "data": {
                "is_heading": 0,
                "text": "CEO Quality"
            },
            "type": "ListItem",
            "sequence_num": 33
        },
        {
            "type": "image",
            "sequence_num": 34,
            "data": {
                "url": "MSEPO-21077 Research management policy.003.png"
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Governance"
            },
            "type": "ListItem",
            "sequence_num": 35
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Committee"
            },
            "type": "ListItem",
            "sequence_num": 36
        },
        {
            "data": {
                "is_heading": 0,
                "text": "CMO"
            },
            "type": "ListItem",
            "sequence_num": 37
        },
        {
            "data": {
                "is_heading": 0,
                "text": "MSEFT R&D"
            },
            "type": "ListItem",
            "sequence_num": 38
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Committee  CommiResteteaerch"
            },
            "type": "ListItem",
            "sequence_num": 39
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Chair"
            },
            "type": "ListItem",
            "sequence_num": 40
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Site Medical Director"
            },
            "type": "ListItem",
            "sequence_num": 41
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Group Head of Research"
            },
            "type": "ListItem",
            "sequence_num": 42
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Figure 1"
            },
            "type": "ListItem",
            "sequence_num": 43
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "The aim of this policy is to provide guidance and support for those undertaking research and to promote high standards of quality, ethics and research governance in all areas of research activity in line with the requirements of the UK policy framework for health and social care published by the Health Research Authority (HRA) in October 2017"
            },
            "type": "ListItem",
            "sequence_num": 44
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The framework sets out 19 principles of good practice in the management and conduct of health and social care research that take appropriate account of legal requirements and other standards (see Appendix 1). These principles protect and promote the interests of patients, services users and the public in health and social care research, by describing ethical conduct and proportionate, assurance-based management of health and social care research, so as to support and facilitate high- quality research in the UK that has the confidence of patients, service users and the public."
            },
            "type": "ListItem",
            "sequence_num": 45
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 1.0,
                "text": "The contents of this Policy are consistent with the principles of the UK policy framework for health and social care research and describe the responsibilities of those involved in research including Chief Investigators (CI), Principal Investigators (PI), research nurses and trial practitioners, sponsors, research sites, regulators, employers and health and social care providers. See section 4 and Appendix"
            },
            "type": "ListItem",
            "sequence_num": 46
        },
        {
            "data": {
                "is_heading": 0,
                "text": "This policy is required reading in Induction Training for new staff and is available on MSEFT's public internet site."
            },
            "type": "ListItem",
            "sequence_num": 47
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 2.0,
                "text": "Scope"
            },
            "type": "ListItem",
            "sequence_num": 48
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.1,
                "text": "This policy describes the framework for all research taking place in MSEFT to ensure compliance with good practice in research whilst not being bureaucratic and not restricting the freedom of individual researchers to develop ideas which have the potential to improve clinical care."
            },
            "type": "ListItem",
            "sequence_num": 49
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.2,
                "text": "The policy is relevant to all staff holding a contract of employment issued by MSEFT who undertake, support or manage clinical research including chief and principal investigators, care professionals, researchers, research nurses, managers and support staff and should be used in conjunction with research Standard Operating Procedures."
            },
            "type": "ListItem",
            "sequence_num": 50
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.3,
                "text": "The policy applies to all research activity involving MSEFT including:"
            },
            "type": "ListItem",
            "sequence_num": 51
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Research where MSEFT is a lead organisation"
            },
            "type": "ListItem",
            "sequence_num": 52
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Research where MSEFT is a participating site in research"
            },
            "type": "ListItem",
            "sequence_num": 53
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Research where participants are patients, carers, volunteers and members of MSEFT staff"
            },
            "type": "ListItem",
            "sequence_num": 54
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Research using patient tissue, organs or data"
            },
            "type": "ListItem",
            "sequence_num": 55
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Research taking place on MSEFT premises"
            },
            "type": "ListItem",
            "sequence_num": 56
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Research involving MSEFT resources"
            },
            "type": "ListItem",
            "sequence_num": 57
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Research that is non-clinical or laboratory based"
            },
            "type": "ListItem",
            "sequence_num": 58
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Research being undertaken as part of an educational qualification"
            },
            "type": "ListItem",
            "sequence_num": 59
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.4,
                "text": "All staff are contractually obligated to follow this Policy as well as any authorised and relevant MSEFT Standard Operating Procedures. Non-compliance with this Policy will be managed in accordance with other MSEFT Policies."
            },
            "type": "ListItem",
            "sequence_num": 60
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 3.0,
                "text": "Definitions"
            },
            "type": "ListItem",
            "sequence_num": 61
        },
        {
            "type": "table",
            "sequence_num": 62,
            "data": {
                "num_rows": 4,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "TERM"
                    },
                    {
                        "text": "DEFINITION"
                    },
                    {
                        "text": "Chief Investigator: (CI)"
                    },
                    {
                        "text": "The CI is the overall lead researcher for a project and is responsible for the overall conduct of the project. See appendix 1 for CI responsibilities"
                    },
                    {
                        "text": "Clinical Research Network (CRN)"
                    },
                    {
                        "text": "Support clinical research infrastructure throughout England, which is working towards increased access for patients to new and better treatments in the NHS. There are 15 local CRNs and we are a member of the North Thames network hosted by Barts Health NHS Trust"
                    },
                    {
                        "text": "Commercial Research"
                    },
                    {
                        "text": "Research that is sponsored by a commercial organisation. Full costs of the research activity are recovered from the company."
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 63,
            "data": {
                "num_rows": 12,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Confirmation of Capacity and Capability (R&D Approval)"
                    },
                    {
                        "text": "Formally known as NHS Permissions, this is research \u2018approval' to start the research project. Research can only review a study for approval once it has received a valid application. It is a serious breach of GCP if any research activity commences before research confirmation has been given"
                    },
                    {
                        "text": "Employers"
                    },
                    {
                        "text": "Employers are the organisation employing the CI and other members of the research team. Excluding those members of the research team whose role in research is not part of their employment e.g. research team members who are patients or service users"
                    },
                    {
                        "text": "Funder"
                    },
                    {
                        "text": "The funder is the organisation or group of organisations that have provided the funding for the research project"
                    },
                    {
                        "text": "Good Clinical Practice (GCP)"
                    },
                    {
                        "text": "GCP is an international ethical and scientific quality standard for designing, conducting, recording and reporting clinical trials"
                    },
                    {
                        "text": "Health and social care providers"
                    },
                    {
                        "text": "Are organisations that provide health or social care. Providers' involvement is generally as research sites, when they are also the employer of members of the research team and responsible for research participants' care. In addition to their responsibilities as a research site, employer and/or sponsor, providers should recognise the importance of research"
                    },
                    {
                        "text": "Health Research Authority (HRA)"
                    },
                    {
                        "text": "The HRA was established in December 2011. Its main purposes, in accordance with the Care Act 2014, are to protect and promote the interest of patients and the public in health and social care research."
                    },
                    {
                        "text": "HRA Approval"
                    },
                    {
                        "text": "HRA Approval is the process for the NHS in England that brings together the assessment of governance and legal compliance, undertaken by dedicated HRA staff, with the independent REC opinion provided through the UK research ethics service"
                    },
                    {
                        "text": "HRA Assessment"
                    },
                    {
                        "text": "Research governance and legal compliance checks undertaken by the HRA"
                    },
                    {
                        "text": "Integrated Research Application System (IRAS)"
                    },
                    {
                        "text": "The single system for applying for the permissions and approvals for health and social care research in the UK ..."
                    },
                    {
                        "text": "Investigator"
                    },
                    {
                        "text": "Person responsible, individually or as leader of the researchers at a site, for the conduct of a study at that site. For clinical trials involving medicines, an investigator must be an authorised health professional."
                    },
                    {
                        "text": "Non- commercial/academic research"
                    },
                    {
                        "text": "Research that has grant funding to meet the research costs and sometimes the research itself, service support costs associated with the study can be met by the NIHR if the study is adopted."
                    },
                    {
                        "text": "National Institute of Health Research (NIHR)"
                    },
                    {
                        "text": "Created in April 2006 under the 2005 Government strategy for health research: Best Research for Best Health3 to improve the health and wealth of the nation through research"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 64,
            "data": {
                "num_rows": 10,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "NIHR Portfolio Adopted Research"
                    },
                    {
                        "text": "The NIHR Portfolio of studies consists of clinical research studies that are funded by a recognised funding partner or commercial company and are eligible for support from the NIHR CRN in England. Locally the studies are supported by NIHR funded staff"
                    },
                    {
                        "text": "Original research"
                    },
                    {
                        "text": "Research developed by employees of MSEFT"
                    },
                    {
                        "text": "Participant:"
                    },
                    {
                        "text": "Patient, service user, carer, relative of the deceased, professional carer, other employee, or member of the public, who consents to take part in a study."
                    },
                    {
                        "text": "Participant Identification Centres (PICs)"
                    },
                    {
                        "text": "An organisation that identifies potential participants for participation in studies not open at their site. NB MSEFT will only agree to PIC status where it is not feasible to open as a substantive research site and, there would be no loss of revenue to MSEFT."
                    },
                    {
                        "text": "Patient and Public Involvement (PPI)"
                    },
                    {
                        "text": "Appropriate involvement of patients and public in the design and management of research studies."
                    },
                    {
                        "text": "Principal Investigator (PI)"
                    },
                    {
                        "text": "The leader responsible for a team of individuals conducting a study at a site."
                    },
                    {
                        "text": "Research"
                    },
                    {
                        "text": "\u201cThe attempt to derive generalisable new knowledge by addressing clearly defined questions with systematic and rigorous methods\u201d"
                    },
                    {
                        "text": "Researchers"
                    },
                    {
                        "text": "Those conducting the research"
                    },
                    {
                        "text": "Research Ethics Committee (REC)"
                    },
                    {
                        "text": "Committee established to provide participants, researchers, funders, sponsors, employers, care organisations and professionals with an independent opinion on the extent to which proposals for a study comply with recognised ethical standards. For clinical trials involving medicines, the ethics committee must be one recognised by the United Kingdom Ethics Committee Authority."
                    },
                    {
                        "text": "Research Fraud and Misconduct"
                    },
                    {
                        "text": "The fabrication, falsification, plagiarism or deception in proposing, carrying out or reporting results of research, or deliberate, dangerous or negligent deviations from accepted practices in carrying out research. It includes failure to follow established protocols if this failure results in unreasonable risk or harm to humans, other vertebrates or the environment, and facilitating of misconduct in research by collusion in, or concealment of, such actions by others. It also includes intentional, unauthorised use, disclosure or removal of, or damage to, research-related property of another, including apparatus, materials, writings or devices used in or produced by the conduct of research. It does not include honest error or honest differences in the design, execution, interpretation or judgement in evaluating research methods or results or misconduct unrelated to the research process. Similarly it does not include poor research unless this encompasses the intention to deceive."
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 65,
            "data": {
                "num_rows": 5,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Research Sponsor"
                    },
                    {
                        "text": "The sponsor is the individual or organisation that takes overall responsibility for proportionate, effective arrangements being in place to set up, run and report the research project. All health and social care research requires a sponsor and it is usually the employer of the CI"
                    },
                    {
                        "text": "Research Team:"
                    },
                    {
                        "text": "The research team is the group of people involved in the conduct of the research project. It may include care professionals, academics, patients and service users, research professionals, scientists and students. Research team members' accountability should be clearly agreed between them and their employer and documented"
                    },
                    {
                        "text": "Responsible care professional"
                    },
                    {
                        "text": "Doctor, nurse, social worker or other practitioner formally responsible for the care of participants while they are taking part in the study."
                    },
                    {
                        "text": "Standard Operating Procedure/s (SOP/s)"
                    },
                    {
                        "text": "A standard operating procedure (SOP) is a set of step-by- step instructions to help staff carry out routine operations with the aim of achieving efficiency, quality output and uniformity of performance and compliance with regulations."
                    },
                    {
                        "text": "Student Research"
                    },
                    {
                        "text": "Any research which is undertaken in fulfilment of a qualification; students can be internal or external"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.0,
                "text": "Role and responsibilities within MSEFT"
            },
            "type": "ListItem",
            "sequence_num": 66
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "The Chief Executive is responsible for:"
            },
            "type": "ListItem",
            "sequence_num": 67
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Demonstrating to relevant approval bodies and sponsors that the location is suitable for the research;"
            },
            "type": "ListItem",
            "sequence_num": 68
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Being aware of all research activity being undertaken in or through the site;"
            },
            "type": "ListItem",
            "sequence_num": 69
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that the roles and responsibilities of individuals at the site and any collaborating parties are agreed and documented for individual research projects; and"
            },
            "type": "ListItem",
            "sequence_num": 70
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Satisfying themselves that, if expected or required, the research has approval from a research ethics committee and any other relevant approval bodies before research participants take part"
            },
            "type": "ListItem",
            "sequence_num": 71
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring that the research activities are conducted in accordance with their applicable legal obligations"
            },
            "type": "ListItem",
            "sequence_num": 72
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring employees are supported in and held to account for conducting research in a professional manner, including research integrity, and"
            },
            "type": "ListItem",
            "sequence_num": 73
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring effective management of employees and their work, including employees' safety, well-being, work environment and facilities,"
            },
            "type": "ListItem",
            "sequence_num": 74
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring financial management and calculation of costs in support of financial probity and"
            },
            "type": "ListItem",
            "sequence_num": 75
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring agreement with their partners and employees about accountability and division of responsibilities, including arrangements for any intellectual property arising from research;"
            },
            "type": "ListItem",
            "sequence_num": 76
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring researchers understand and discharge their responsibilities;"
            },
            "type": "ListItem",
            "sequence_num": 77
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Following good HR practice"
            },
            "type": "ListItem",
            "sequence_num": 78
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Providing written procedures, supervision and training that support accountability and effective collaboration"
            },
            "type": "ListItem",
            "sequence_num": 79
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring research income is appropriately managed"
            },
            "type": "ListItem",
            "sequence_num": 80
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Raising awareness of the wider environment within which health and social care research is conducted"
            },
            "type": "ListItem",
            "sequence_num": 81
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Taking proportionate, effective action in the event of errors and breaches or if misconduct or fraud are suspected."
            },
            "type": "ListItem",
            "sequence_num": 82
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Ensuring appropriate individual learning and competence."
            },
            "type": "ListItem",
            "sequence_num": 83
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.2,
                "text": "The Chief Medical Officer is responsible for providing assurance to the Chief Executive, through the approved governance structure, for their responsibilities."
            },
            "type": "ListItem",
            "sequence_num": 84
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.3,
                "text": "The Group Head of Research is responsible for ensuring all members of the research team are aware of this standard operating procedure and reporting compliance to the MSEFT Research and Development Committee."
            },
            "type": "ListItem",
            "sequence_num": 85
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.4,
                "text": "The Research and Development Committee is responsible for implementation and monitoring this policy and recommending any changes for approval by the Governance Quality Committee"
            },
            "type": "ListItem",
            "sequence_num": 86
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.5,
                "text": "Line Managers are responsible for ensuring their staff, where appropriate, are aware of this standard operating procedure"
            },
            "type": "ListItem",
            "sequence_num": 87
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.6,
                "text": "Trust Staff are responsible for implementing and complying with this standard operating procedure within the areas of their control."
            },
            "type": "ListItem",
            "sequence_num": 88
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.7,
                "text": "The Chief Investigator (CI) is the overall lead researcher for a project and are responsible for the overall conduct of the project."
            },
            "type": "ListItem",
            "sequence_num": 89
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.8,
                "text": "The Research Team is the group of people involved in the conduct of the research project. It may include care professionals, academics, patients and service users, research professionals, scientists and students. Research team members' accountability should be clearly agreed between them and their employer and documented."
            },
            "type": "ListItem",
            "sequence_num": 90
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.9,
                "text": "The Funder is the organisation or group of organisations that have provided the funding for the research project."
            },
            "type": "ListItem",
            "sequence_num": 91
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.1,
                "text": "The Sponsor is the individual or organisation that takes overall responsibility for proportionate, effective arrangements being in place to set up, run and report the research project. All health and social care research requires a sponsor and it is usually the employer of the CI."
            },
            "type": "ListItem",
            "sequence_num": 92
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.11,
                "text": "Research Sites are the organisations that have the day-to-day responsibility for the locations where the research is taking place."
            },
            "type": "ListItem",
            "sequence_num": 93
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.12,
                "text": "Regulators of professions such as General Medical Council, Nursing and Midwifery Council are responsible for professional standards and ensuring compliance with the standards of the UK policy framework e.g. assessing fitness to practice."
            },
            "type": "ListItem",
            "sequence_num": 94
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.13,
                "text": "Other Regulators are statutory bodies that oversee particular activities set out in legislation. There are a number of regulators in the UK with a remit for activities associated with health and social care research; the Health Research Authority (HRA) the Human Fertilisation and Embryology Authority, the human Tissue Authority (HTA) and the Medicines and Healthcare products Regulatory Agency (MHRA)"
            },
            "type": "ListItem",
            "sequence_num": 95
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.14,
                "text": "Employers are the organisation employing the CI and other members of the research team. Excluding those members of the research team whose role in research is not part of their employment e.g. research team members who are patients or service users"
            },
            "type": "ListItem",
            "sequence_num": 96
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 4.15,
                "text": "Health and social care providers are organisations that provide health or social care. Providers' involvement is generally as research sites, when they are also the employer of members of the research team and responsible for research participants' care. In addition to their responsibilities as a research site, employer and/or sponsor, providers should recognise the importance of research by the responsibilities outlined in the UK policy framework"
            },
            "type": "ListItem",
            "sequence_num": 97
        },
        {
            "data": {
                "is_heading": 0,
                "text": "See Appendix 2 Responsibilities Framework"
            },
            "type": "ListItem",
            "sequence_num": 98
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 5.0,
                "text": "Confirming capability and capacity for research projects"
            },
            "type": "ListItem",
            "sequence_num": 99
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "All research taking place within MSEFT must have confirmation of capability and capacity (C&C) before any research activity begins. MSEFT will only extend NHS Indemnity cover (for negligent harm) to its employees taking part in research studies that have received confirmation of C&C. MSEFT will not accept liability for research that has not received confirmation of C&C."
            },
            "type": "ListItem",
            "sequence_num": 100
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.2,
                "text": "All research must have an identified sponsor. The sponsor is the institution that takes overall responsibility for the initiation, financing, management and monitoring of a study. For commercially initiated research, the commercial company would be expected to act as research sponsor. Evidence of research sponsorship will be required before Trust approval is granted."
            },
            "type": "ListItem",
            "sequence_num": 101
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.3,
                "text": "MSEFT may act as Sponsor but this must be discussed with the Group Head of Research before submission to IRAS and may require approval from the R&D Committee."
            },
            "type": "ListItem",
            "sequence_num": 102
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.4,
                "text": "Agreement to sponsor a study may be suspended or withdrawn if during the course of a study:"
            },
            "type": "ListItem",
            "sequence_num": 103
        },
        {
            "data": {
                "is_heading": 0,
                "text": "a) the safety of participants is at risk;"
            },
            "type": "ListItem",
            "sequence_num": 104
        },
        {
            "data": {
                "is_heading": 0,
                "text": "b) the CI is no longer employed by MSEFT and a suitable replacement cannot be obtained;"
            },
            "type": "ListItem",
            "sequence_num": 105
        },
        {
            "data": {
                "is_heading": 0,
                "text": "c) there is a breach of any research Standard Operating Procedures (SOPs); and /or"
            },
            "type": "ListItem",
            "sequence_num": 106
        },
        {
            "data": {
                "is_heading": 0,
                "text": "d) if there is suspicion of, or an accusation of research misconduct, fraud or serious breach of GCP (see Section 5.8)."
            },
            "type": "ListItem",
            "sequence_num": 107
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.5,
                "text": "For original research, Research will work with the CI to develop the research, ensuring necessary collaborations, that appropriate patient and public involvement (PPI) and peer review is in place, sourcing funding, developing research documents (e.g. protocol, participant information sheets), completing IRAS and applying for necessary approvals both internal and external. The research would then undergo review as below."
            },
            "type": "ListItem",
            "sequence_num": 108
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.6,
                "text": "For portfolio adopted research, in conjunction with the PI, research staff will ensure the research is feasible to run within MSEFT, this feasibility assessment will include;"
            },
            "type": "ListItem",
            "sequence_num": 109
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "a) Sourcing and reviewing the valid application and HRA approval"
            },
            "type": "ListItem",
            "sequence_num": 110
        },
        {
            "data": {
                "is_heading": 0,
                "text": "b) Review Caldecott, data protection/data transfer requirements"
            },
            "type": "ListItem",
            "sequence_num": 111
        },
        {
            "data": {
                "is_heading": 0,
                "text": "c) Consider IT, procurement and MEMS"
            },
            "type": "ListItem",
            "sequence_num": 112
        },
        {
            "data": {
                "is_heading": 0,
                "text": "d) Completing feasibility proforma"
            },
            "type": "ListItem",
            "sequence_num": 113
        },
        {
            "data": {
                "is_heading": 0,
                "text": "e) Liaising with all areas which may be impacted by the research"
            },
            "type": "ListItem",
            "sequence_num": 114
        },
        {
            "data": {
                "is_heading": 0,
                "text": "f) Completing a full costing of the research activity"
            },
            "type": "ListItem",
            "sequence_num": 115
        },
        {
            "data": {
                "is_heading": 0,
                "text": "g) Advising the Group Head of Research"
            },
            "type": "ListItem",
            "sequence_num": 116
        },
        {
            "data": {
                "is_heading": 0,
                "text": "h) Sending feasibility proforma to MSE Clinical Director/Clinical Lead/Deputy Director of Nursing and relevant areas for C&C \u2018sign-off' (electronic or wet signature on proforma or e-mail assent)"
            },
            "type": "ListItem",
            "sequence_num": 117
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.7,
                "text": "MSEFT will only support student research for masters level and doctoral students that can apply for ethics review and/or HRA approval (see HRA). The primary responsibility for the student and their research would fall onto their academic institution/academic supervisor and MSEFT would expect the academic institution to act as sponsor for these studies. Research will support the student through the process ensuring there is proportionate clinical supervision. For students not employed by MSEFT, Research would also guide the student through the Research Passport process (see Section 11)."
            },
            "type": "ListItem",
            "sequence_num": 118
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.8,
                "text": "MSEFT will ensure that when considering whether or not to support a particular research study at a site there is a detailed consideration of the following:"
            },
            "type": "ListItem",
            "sequence_num": 119
        },
        {
            "data": {
                "is_heading": 1,
                "text": "a) Assess: Assessing whether or not the site has the capacity and capability* to participate in the study."
            },
            "type": "ListItem",
            "sequence_num": 120
        },
        {
            "data": {
                "is_heading": 1,
                "text": "b) Arrange: Assessing that practical arrangements can be put in place to provide the capacity and capability to deliver the study."
            },
            "type": "ListItem",
            "sequence_num": 121
        },
        {
            "data": {
                "is_heading": 1,
                "text": "c) Confirm: Confirming that MSEFT has the capacity and capability in place to deliver the study and that it will deliver the study to time and target."
            },
            "type": "ListItem",
            "sequence_num": 122
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.9,
                "text": "To provide a cohesive, joined-up and pragmatic process will not duplicate any activity undertaken as part of the HRA Assessment."
            },
            "type": "ListItem",
            "sequence_num": 123
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.1,
                "text": "Confirmation of C&C is sent by e-mail to the sponsor, with a copy to the CI/PI and North Thames CRN if portfolio adopted."
            },
            "type": "ListItem",
            "sequence_num": 124
        },
        {
            "data": {
                "is_heading": 0,
                "text": "*The majority of research sponsored and hosted by MSEFT will be late phase II onwards, however consideration will be given to first in human (FIH) and Phase I studies on a study by study basis. A thorough review, detailed risk assessment and discussion and agreement of responsibilities with the CI/PI/sponsor, Head of Research and R&D Committee will be undertaken before a decision is made to sponsor and/or host FIH and Phase I trials of medicinal products or devices"
            },
            "type": "ListItem",
            "sequence_num": 125
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 6.0,
                "text": "Ethical practice"
            },
            "type": "ListItem",
            "sequence_num": 126
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.1,
                "text": "The dignity, rights, safety and wellbeing of participants must be the primary consideration in any research study. Research involving patients, service users, care professionals or volunteers, or their organs, tissue or data must be reviewed independently to ensure it meets ethical standards."
            },
            "type": "ListItem",
            "sequence_num": 127
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "For all research which falls within the remit of the Governance Arrangements for Research Ethics Committees (GafREC) review from a recognised NHS Research Ethics Committee (REC) is required."
            },
            "type": "ListItem",
            "sequence_num": 128
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.3,
                "text": "All research at MSEFT must be submitted for regulatory review via the Integrated Research Application System (IRAS) https://www.myresearchproject.org.uk/  This is a single system for applying for the permissions and approvals for health and social care / community care research in the UK."
            },
            "type": "ListItem",
            "sequence_num": 129
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.4,
                "text": "IRAS captures the information needed for the relevant approvals from the following review bodies:"
            },
            "type": "ListItem",
            "sequence_num": 130
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Administration of Radioactive Substances Advisory Committee (ARSAC)"
            },
            "type": "ListItem",
            "sequence_num": 131
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Confidentiality Advisory Group (CAG)"
            },
            "type": "ListItem",
            "sequence_num": 132
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Gene Therapy Advisory Committee (GTAC)"
            },
            "type": "ListItem",
            "sequence_num": 133
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Health Research Authority (HRA) for projects seeking HRA Approval"
            },
            "type": "ListItem",
            "sequence_num": 134
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Medicines and Healthcare products Regulatory Agency (MHRA)"
            },
            "type": "ListItem",
            "sequence_num": 135
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NHS / HSC Research Offices"
            },
            "type": "ListItem",
            "sequence_num": 136
        },
        {
            "data": {
                "is_heading": 0,
                "text": "NHS / HSC Research Ethics Committees"
            },
            "type": "ListItem",
            "sequence_num": 137
        },
        {
            "data": {
                "is_heading": 0,
                "text": "National Offender Management Service"
            },
            "type": "ListItem",
            "sequence_num": 138
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Social Care Research Ethics Committee"
            },
            "type": "ListItem",
            "sequence_num": 139
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.5,
                "text": "For many studies informed consent from participants is essential and consent must be sought in the way agreed during ethical review and relevant MSEFT Research SOPs"
            },
            "type": "ListItem",
            "sequence_num": 140
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "All clinical trials, given a favourable opinion by a REC within the Health Departments' Research Ethics Service and currently in active recruitment in the UK, have been registered on a publically accessible register (clinicaltrials.gov) in"
            },
            "type": "ListItem",
            "sequence_num": 141
        },
        {
            "data": {
                "is_heading": 0,
                "text": "compliance with existing duties of sponsors and the HRA requirements and extended compliance checks."
            },
            "type": "ListItem",
            "sequence_num": 142
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.7,
                "text": "Pharmacy Please see the Pharmacy MSEFT Clinical Trial SOPs"
            },
            "type": "ListItem",
            "sequence_num": 143
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.8,
                "text": "Pathology"
            },
            "type": "ListItem",
            "sequence_num": 144
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "MSEFT staff working within Pathology Research will comply with local Research policies or equivalent and study specific laboratory manuals. All staff would have completed site specific competency assessments or equivalent, have a valid GCP and International Air Transport Association (transfer of biological samples) certificate prior to undertaking research specific activities. Under the Human Tissue Act 2004, pathology are legally able to store tissue and samples for studies that"
            },
            "type": "ListItem",
            "sequence_num": 145
        },
        {
            "data": {
                "is_heading": 0,
                "text": "have ethical approval. All laboratories will have, or are actively working towards, UK Accreditation Scheme accreditation."
            },
            "type": "ListItem",
            "sequence_num": 146
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.9,
                "text": "Amendments"
            },
            "type": "ListItem",
            "sequence_num": 147
        },
        {
            "data": {
                "is_heading": 0,
                "text": "For various reasons during the course of a study the valid application needs to be amended. The amendment may be classified as substantive (has significant impact on participants or scientific value of the study) and non-substantive. Amendments are submitted to the HRA for categorisation and review. All amendments will be reviewed to ensure that the study remains feasible to run at MSEFT and confirmation will be sent to the sponsor, PI and research team."
            },
            "type": "ListItem",
            "sequence_num": 148
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 7.0,
                "text": "Study progress and performance management"
            },
            "type": "ListItem",
            "sequence_num": 149
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.1,
                "text": "CIs are required to submit annual progress reports to ethics copying in the Quality Facilitator."
            },
            "type": "ListItem",
            "sequence_num": 150
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.2,
                "text": "The PI for each project is responsible for efficient and ethical management of all aspects of the project and is required to ensure all trial documentation is in order and available for internal and external audit and inspection."
            },
            "type": "ListItem",
            "sequence_num": 151
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.3,
                "text": "It is the responsibility of the PI to inform the R&D when a study has ended. The definition of end of trial or study should be included in the study protocol however if this is absent, the date of the last patient completing last visit will be used."
            },
            "type": "ListItem",
            "sequence_num": 152
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.4,
                "text": "Research is required to report specific performance management criteria which for portfolio adopted studies is related directly to the level of income received from the NIHR."
            },
            "type": "ListItem",
            "sequence_num": 153
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 62.0,
                "text": "Research is also required to submit quarterly performance in initiating and delivering clinical research data to the NIHR Central Commissioning Facility. These are key performance indicators that we are expected to meet when initiating and delivering clinical trials and include the time taken from valid application to issuing confirmation, target 40 days and time from valid application to first patient recruited; target mean of 80 days for commercially sponsored research and  days for non-commercial. For commercially sponsored NIHR clinical trials we are expected to meet the target we agreed in the time we agreed as outlined in the contract."
            },
            "type": "ListItem",
            "sequence_num": 154
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.6,
                "text": "The research department follow an annual quality management framework programme including a research governance audit, an event reporting audit, reviews of risk assessments, monitoring reports and letters of access."
            },
            "type": "ListItem",
            "sequence_num": 155
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 8.0,
                "text": "Financial management"
            },
            "type": "ListItem",
            "sequence_num": 156
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.1,
                "text": "All Research Accounts have to be used in accordance with MSEFT's Standing Orders and Standing Financial Instructions. Systems to ensure financial probity are a legal requirement for all projects. Researchers planning original research are required to liaise with research management to agree costing and workforce requirements for grant applications where applicable prior to grant application submission. There must be transparency and accountability of all research income and expenditure."
            },
            "type": "ListItem",
            "sequence_num": 157
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "The Attributing the Costs of Health and Social Care Research and Development (AcoRD) provides a framework for the NHS and its partners to identify, attribute"
            },
            "type": "ListItem",
            "sequence_num": 158
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.0,
                "text": "and recover the various costs associated with research in the NHS in a transparent, robust and consistent manner. 8.3  The research costs of all projects funded via external grant applications, commercial agreements or the internal funding system will be calculated using the NIHR industry costing template by the research office. This is to ensure that the financial risks to research and MSEFT can be anticipated and managed."
            },
            "type": "ListItem",
            "sequence_num": 159
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.4,
                "text": "The research office, in conjunction with the research team, is responsible for raising the necessary invoices via finance."
            },
            "type": "ListItem",
            "sequence_num": 160
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.5,
                "text": "Income from commercial activity will be managed according to MSEFT's Commercial income distribution policy."
            },
            "type": "ListItem",
            "sequence_num": 161
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 9.0,
                "text": "Data protection"
            },
            "type": "ListItem",
            "sequence_num": 162
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.0,
                "text": "The Data Protection Act demands that organisations have a valid, legal reason to process and use personal data. Patient data is only accessed by researchers who have obtained ethical and HRA approval and Trust confirmation for their study and who understand their responsibilities with regard to data protection regulations, particularly ensuring patient anonymity and confidentiality. In some circumstances this may not be possible and within the legal frameworks there are mechanisms to provide exemption to this where consent is not practicable or would be inappropriate, both in relation to confidential patient information and human tissue samples in research. Expert advice is to be sought if legal exemption is required."
            },
            "type": "ListItem",
            "sequence_num": 163
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.0,
                "text": "The UK General Data Protection Regulations(UK GDPR) introduces the requirement for explicit consent, which is in line with good research practice undertaken at MSEFT. Questionnaire research studies that collect personal and/or sensitive data by means of implicit consent will be discussed with MSEFT's Data Protection Officer."
            },
            "type": "ListItem",
            "sequence_num": 164
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.0,
                "text": "The MSEFT Information Governance & Management Policy and Information Governance Handbook are available for researchers. Researchers are required to have read the guidance and made arrangements for appropriate storage of research documentation."
            },
            "type": "ListItem",
            "sequence_num": 165
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.4,
                "text": "MSEFT will ensure that appropriate arrangements are in place to archive data when the research has finished and to make it accessible."
            },
            "type": "ListItem",
            "sequence_num": 166
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.0,
                "text": "The National Data Opt Out allows a patient to choose if they do not want their confidential data to be used for purposes beyond their individual care and treatment for research and planning and MSEFT ensure this by having the appropriate guidance and mechanisms in place to allow staff to verify NHS numbers prior to secondary usage. Further details are available in the Trust National Data Opt Out Policy (MSEPO \u2013 20207)."
            },
            "type": "ListItem",
            "sequence_num": 167
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 10.0,
                "text": "Good clinical practice training (GCP)"
            },
            "type": "ListItem",
            "sequence_num": 168
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.1,
                "text": "Everyone involved in the conduct of clinical research must have training to ensure they are best prepared to carry out their duties. It is the responsibility of the Principal Investigator to be satisfied that the local research team are trained to deliver the study"
            },
            "type": "ListItem",
            "sequence_num": 169
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.2,
                "text": "The principles of GCP state that \u201cEach individual involved in conducting a trial should be qualified by education, training and experience to perform his or her respective task(s)\u201d."
            },
            "type": "ListItem",
            "sequence_num": 170
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.0,
                "text": "The Medicines for Human Use (Clinical Trials) (2004) regulations require that all staff are trained to carry out their duties on each study they are working on. All staff"
            },
            "type": "ListItem",
            "sequence_num": 171
        },
        {
            "data": {
                "is_heading": 0,
                "text": "listed on the delegation log of a clinical trial involving medicinal products (CTIMPS) must have a valid GCP training certificate and this policy recommends all staff involved in non-interventional studies also hold a valid GCP certificate. MSEFT recommend that GCP is renewed every 2-3 years but the this will vary according to the sponsor. GCP training can be accessed as either a taught course or online through e-learning."
            },
            "type": "ListItem",
            "sequence_num": 172
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 11.0,
                "text": "Indemnity"
            },
            "type": "ListItem",
            "sequence_num": 173
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.1,
                "text": "MSE participates in the NHS risk pooling scheme administered by the NHS Litigation Authority \u201cClinical Negligence Scheme for NHS Trusts\u201d for medical professional and/or medical malpractice liability, and general liability"
            },
            "type": "ListItem",
            "sequence_num": 174
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.2,
                "text": "NHS indemnity for negligent harm is extended to researchers with an employment contract (substantive or honorary) with MSEFT. MSEFT only accepts liability for research activity that has had MSEFT C&C."
            },
            "type": "ListItem",
            "sequence_num": 175
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.3,
                "text": "For commercial CTIMP studies, commercial companies will be expected to provide cover for negligent and non-negligent harm under the standard Clinical Trial Compensation Guidelines recommended by the Association of the British Pharmaceutical Industry. This should be clearly outlined in the Clinical Trial"
            },
            "type": "ListItem",
            "sequence_num": 176
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Agreement."
            },
            "type": "ListItem",
            "sequence_num": 177
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 12.0,
                "text": "Contracts and agreements"
            },
            "type": "ListItem",
            "sequence_num": 178
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.0,
                "text": "For commercial CTIMPs or commercial studies involving medical devices MSEFT expects that commercial companies will use the national model Clinical Trial Agreements for pharmaceutical companies working with the NHS."
            },
            "type": "ListItem",
            "sequence_num": 179
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.2,
                "text": "When MSEFT conducts research involving non-commercial partner organisations the allocation of responsibilities should be clearly documented."
            },
            "type": "ListItem",
            "sequence_num": 180
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.0,
                "text": "For non-commercial studies and where agreements are required, MSEFT expects that other non-commercial partners will use the national model Non-Commercial Agreement which will be superseded by a revised version to be issued by the Health Research Authority. Where no contract is required the HRA Organisational Information Document (OID) will be used for site agreement."
            },
            "type": "ListItem",
            "sequence_num": 181
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 13.0,
                "text": "Research personnel"
            },
            "type": "ListItem",
            "sequence_num": 182
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.1,
                "text": "The safety of research participants and research staff must be given priority at all times."
            },
            "type": "ListItem",
            "sequence_num": 183
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.2,
                "text": "The MSEFT Health and Safety Policy (MSEPO 20209) must be strictly observed during the course of the research. This is particularly important if the research involves the use of potentially dangerous or harmful equipment, substances or organisms."
            },
            "type": "ListItem",
            "sequence_num": 184
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.0,
                "text": "It is the responsibility of the CI or PI at each site, to ensure staff have the necessary contracts or letters of access in place before staff begin research work within MSEFT and they should contact the R&D Department for advice and issuing of appropriate contracts. Researchers not employed by any NHS organisation who interact with research participants in a way that has a direct bearing on the quality of their care should hold an NHS Honorary Research Contract, Letter of Access or Research Passportas appropriate. Other arrangements will be made for non-NHS staff where their research does not have a bearing on the quality of patient care. Staff employed to support research may need to be flexible and provide support where appropriate, and as needed, across sites within MSEFT."
            },
            "type": "ListItem",
            "sequence_num": 185
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.4,
                "text": "For research undertaken by a student(s) in fulfilment of educational qualifications below doctoral level, the academic supervisor will take on the role of CI."
            },
            "type": "ListItem",
            "sequence_num": 186
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.5,
                "text": "It is normally expected that a doctoral student undertaking a project will be named as the CI rather than the academic supervisor. However, in some cases it may be more appropriate for a clinical supervisor to take on the role of CI for a project undertaken by a doctoral student."
            },
            "type": "ListItem",
            "sequence_num": 187
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 14.0,
                "text": "Peer review"
            },
            "type": "ListItem",
            "sequence_num": 188
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.1,
                "text": "All projects where MSEFT is Sponsor will require appropriate peer review that is independent i.e. no conflicts of interest, expert, in terms of understanding of the clinical and research methodologies and outcomes and recorded."
            },
            "type": "ListItem",
            "sequence_num": 189
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.2,
                "text": "All non-commercial research that is externally Sponsored and funded via grants from research councils or major charities will have already been subject to peer review."
            },
            "type": "ListItem",
            "sequence_num": 190
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.3,
                "text": "For commercially sponsored projects, it is the responsibility of the commercial sponsor to arrange peer review."
            },
            "type": "ListItem",
            "sequence_num": 191
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.4,
                "text": "For non-doctoral student projects, peer review by the individual's supervisor should normally be adequate."
            },
            "type": "ListItem",
            "sequence_num": 192
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 15.0,
                "text": "Fraud and misconduct in research"
            },
            "type": "ListItem",
            "sequence_num": 193
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.1,
                "text": "Whilst pursuing research, NHS Trusts must ensure that there are proper systems and processes to protect and safeguard the wellbeing of both participants and researchers. MSEFT is committed to maintaining the integrity and probity of research undertaken and will thoroughly investigate any allegations of misconduct in research made against employees of the Trust."
            },
            "type": "ListItem",
            "sequence_num": 194
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.2,
                "text": "Individuals who wish to make a complaint or allegation of research fraud/ misconduct should contact their General Manager/Clinical Director, Medical Director, Group Head of Research or through recommended channels for raising concerns (see the MSEFT Whistleblowing Policy, or equivalent). MSEFT wish to ensure that a culture of openness is fostered and that there exists a research environment that supports the raising of legitimate concerns. However, where it is found that the complaint is made on malicious or vexatious grounds, disciplinary action will be considered."
            },
            "type": "ListItem",
            "sequence_num": 195
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.3,
                "text": "There are a number of distinct stages in which complaints of an alleged case of research misconduct and fraud will be dealt. These stages are set out below. This is an independent process which can feed into and, if required, inform, the Workforce Investigation Policy, or equivalent."
            },
            "type": "ListItem",
            "sequence_num": 196
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Informal stage"
            },
            "type": "ListItem",
            "sequence_num": 197
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The complaint or concern may be resolved informally without a need for referral to the formal stages. If there is any doubt as to the seriousness of the matter, then the Medical Director or Group Head of Research must be consulted."
            },
            "type": "ListItem",
            "sequence_num": 198
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Formal stage"
            },
            "type": "ListItem",
            "sequence_num": 199
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Once the Medical Director/Group Head of Research receives communication of a"
            },
            "type": "ListItem",
            "sequence_num": 200
        },
        {
            "data": {
                "is_heading": 0,
                "text": "formal complaint they will request the complainant to provide a detailed written statement in support of the allegation and inform the researcher that an anonymised complaint/concern has been made, and that it will be investigated by the Group."
            },
            "type": "ListItem",
            "sequence_num": 201
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Head of Research supported by an appropriate member of the Research and"
            },
            "type": "ListItem",
            "sequence_num": 202
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Development Committee and a nominee of the Medical Director."
            },
            "type": "ListItem",
            "sequence_num": 203
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.4,
                "text": "The initial investigation will take no longer than 7 days, and inform the Medical Director whether or not there is:"
            },
            "type": "ListItem",
            "sequence_num": 204
        },
        {
            "data": {
                "is_heading": 0,
                "text": "No case the answer,"
            },
            "type": "ListItem",
            "sequence_num": 205
        },
        {
            "data": {
                "is_heading": 0,
                "text": "There is no case but malicious intent,"
            },
            "type": "ListItem",
            "sequence_num": 206
        },
        {
            "data": {
                "is_heading": 0,
                "text": "A minor concern or"
            },
            "type": "ListItem",
            "sequence_num": 207
        },
        {
            "data": {
                "is_heading": 0,
                "text": "A major concern."
            },
            "type": "ListItem",
            "sequence_num": 208
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.5,
                "text": "Where there is no case to answer, the researcher and complainant to be informed. Where there is no case but malicious intent the researcher to be informed. The Personnel Department will then be informed for relevant action to be taken in respect of the complainant."
            },
            "type": "ListItem",
            "sequence_num": 209
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.6,
                "text": "Where there is a minor concern, the investigators should recommend actions for resolution of the concern for the Medical Director to consider and action if appropriate."
            },
            "type": "ListItem",
            "sequence_num": 210
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 15.7,
                "text": "Where there is a major concern, the complaint should be escalated and the Medical Director advised to report the issue(s) according to the employers Conduct & Capability Policy, or equivalent."
            },
            "type": "ListItem",
            "sequence_num": 211
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Appeal process"
            },
            "type": "ListItem",
            "sequence_num": 212
        },
        {
            "data": {
                "is_heading": 0,
                "text": "There is no right of appeal in respect to research-practice recommendations for minor concerns."
            },
            "type": "ListItem",
            "sequence_num": 213
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Where disciplinary action has been invoked, the researcher will have access to a right of appeal through his/her employer's disciplinary procedure. If no disciplinary action has been invoked and the researcher wishes to appeal against the process of the investigation, then an appeal should be submitted under the appropriate Grievance and Disputes Procedure."
            },
            "type": "ListItem",
            "sequence_num": 214
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Incident Reporting"
            },
            "type": "ListItem",
            "sequence_num": 215
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All appropriate and reporting incidents should be reported within the Trust according to standard practice and procedures. Where appropriate, the Research Department will report adverse events and protocol breaches to the relevant Trial Centre's, Sponsors and/or Ethics Committees."
            },
            "type": "ListItem",
            "sequence_num": 216
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Reporting"
            },
            "type": "ListItem",
            "sequence_num": 217
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The levels of reporting will be governed by: the outcome of the particular stage of the review process; the main employer status; the conditions set by funding body, and the regulations set by any relevant professional body."
            },
            "type": "ListItem",
            "sequence_num": 218
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Documentation"
            },
            "type": "ListItem",
            "sequence_num": 219
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Comprehensive and careful notes should be taken at each stage of the review process."
            },
            "type": "ListItem",
            "sequence_num": 220
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All notes should be stored in a safe and secure environment during the process, and to be filed with the Personnel Department once the matter is concluded. All documentation should be handled in accordance with the provisions of the current UK Data Protection Act'"
            },
            "type": "ListItem",
            "sequence_num": 221
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 16.0,
                "text": "Involving consumers in research"
            },
            "type": "ListItem",
            "sequence_num": 222
        },
        {
            "data": {
                "is_heading": 0,
                "text": "MSEFT will require evidence of the involvement of patients, service users and public in the design, management, conduct and dissemination of research that it is sponsoring."
            },
            "type": "ListItem",
            "sequence_num": 223
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 17.0,
                "text": "Intellectual property (IP) rights"
            },
            "type": "ListItem",
            "sequence_num": 224
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.1,
                "text": "All projects are reviewed to consider the potential intellectual property (IP) rights before ethical approval is given."
            },
            "type": "ListItem",
            "sequence_num": 225
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.2,
                "text": "The MSEFT IP Policy, or equivalent, outlines the principles of IP Management in MSEFT and identifies an IP Lead."
            },
            "type": "ListItem",
            "sequence_num": 226
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 18.0,
                "text": "Publication of research"
            },
            "type": "ListItem",
            "sequence_num": 227
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.1,
                "text": "There is the expectation, by research and under the terms of the ethics application, that all research sponsored research will be published, whether a positive or negative outcome was demonstrated. All publications from research studies sponsored by MSEFT should be copied to Research prior to submission for publication"
            },
            "type": "ListItem",
            "sequence_num": 228
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "ClinicalTrials.gov is a registry and results database of publicly and privately supported clinical studies of human participants. All original research sponsored by MSEFT will be recorded at this site and complete all the fields associated, including results and outcomes."
            },
            "type": "ListItem",
            "sequence_num": 229
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.3,
                "text": "The Division(s) under which the research is undertaken should meet the costs of publication however, the Group Head of Research will consider approving the use of commercial surplus associated with the first author."
            },
            "type": "ListItem",
            "sequence_num": 230
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.4,
                "text": "MSEFT does not have automatic rights to publish research it does not sponsor i.e. portfolio adopted research and some commercial R&D sponsored research (due to its commercial sensitivity). It is therefore not acceptable for researchers undertaking these projects to publish or disseminate these data outside MSEFT."
            },
            "type": "ListItem",
            "sequence_num": 231
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.5,
                "text": "Findings (including negative findings) should be published in a way that allows critical review and dissemination through the accepted scientific and professional channels. Findings must be made accessible to those participating in research and to those who could benefit from them."
            },
            "type": "ListItem",
            "sequence_num": 232
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.6,
                "text": "MSEFT will actively support and encourage dissemination of research findings at local, regional, national and international meetings."
            },
            "type": "ListItem",
            "sequence_num": 233
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 19.0,
                "text": "Training requirements"
            },
            "type": "ListItem",
            "sequence_num": 234
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 19.1,
                "text": "MSEFT staff will be expected to adhere to the mandatory training programme and Training Needs analysis which will be monitored as part of the appraisal process (see relevant research SOP)."
            },
            "type": "ListItem",
            "sequence_num": 235
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "MSEFT involved in the conduct of clinical research is required to have the training to ensure they are best prepared to carry out their duties. Principleof the uk policy framework states that 2all the people involved in managing and conducting a research project are qualified by education, training and experience, or otherwise competent under the supervision of a suitably qualified person, to perform their tasks\u201d. The responsibility for ensuring those involved in research have the required training falls to the organisation employing the staff, the sponsor the CI and the PI depending on who is sponsoring the study. Section 5.8 outlines the GCP training requirements that are a minimum for most studies."
            },
            "type": "ListItem",
            "sequence_num": 236
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 19.3,
                "text": "Individual studies may require trial specific training which is provided by the sponsor and it will be CP/PIs responsibility to ensure the team meet those specific requirements."
            },
            "type": "ListItem",
            "sequence_num": 237
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 20.0,
                "text": "Monitoring and audit"
            },
            "type": "ListItem",
            "sequence_num": 238
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.1,
                "text": "The effectiveness of this policy will be monitored through the annual R&D quality management plan including the following:"
            },
            "type": "ListItem",
            "sequence_num": 239
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Project review"
            },
            "type": "ListItem",
            "sequence_num": 240
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Annual research and development review"
            },
            "type": "ListItem",
            "sequence_num": 241
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Audit plans for Trust Sponsored projects"
            },
            "type": "ListItem",
            "sequence_num": 242
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Annual Report submitted to the Trust Board"
            },
            "type": "ListItem",
            "sequence_num": 243
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Involvement in external/internal audit/inspection."
            },
            "type": "ListItem",
            "sequence_num": 244
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 20.2,
                "text": "Outlined below is the MSEFT's process of monitoring compliance with, and the effectiveness of the document's main points."
            },
            "type": "ListItem",
            "sequence_num": 245
        },
        {
            "type": "table",
            "sequence_num": 246,
            "data": {
                "num_rows": 2,
                "num_cols": 6,
                "table_items": [
                    {
                        "text": "Aspect of compliance or effectiveness being monitored"
                    },
                    {
                        "text": "Monitoring Method"
                    },
                    {
                        "text": "Individual department responsible for the monitoring"
                    },
                    {
                        "text": "Frequency of the monitoring activity"
                    },
                    {
                        "text": "Group / Committee / forum which will receive the exception findings/monitoring report"
                    },
                    {
                        "text": "Committee / individual responsible for ensuring the actions are completed"
                    },
                    {
                        "text": "Quality Management Programme"
                    },
                    {
                        "text": "Audit and monitoring"
                    },
                    {
                        "text": "Team Leader"
                    },
                    {
                        "text": "Annual"
                    },
                    {
                        "text": "R&D Committee"
                    },
                    {
                        "text": "R&D Committee"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 21.0,
                "text": "Approval and implementation"
            },
            "type": "ListItem",
            "sequence_num": 247
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.1,
                "text": "All policies, procedures and guidelines will be approved by the R&D Committee, which is the specialist group with the authority to approve local policies and guidelines. These will then be forwarded to the Document control team for submission and ratification by the Joint Document Management Group."
            },
            "type": "ListItem",
            "sequence_num": 248
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.2,
                "text": "It is the author's responsibility to inform the R&D Committee of the approved policy documents when they are uploaded to the Trust's Intranets."
            },
            "type": "ListItem",
            "sequence_num": 249
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 21.3,
                "text": "This document will be available electronically on the Trust intranet and staff will be informed of any updates via the Hub. Hard copies of the policy will be available via designated hard copy libraries in accordance with the Controlled Documents policy."
            },
            "type": "ListItem",
            "sequence_num": 250
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 22.0,
                "text": "Equality impact assessment"
            },
            "type": "ListItem",
            "sequence_num": 251
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 22.1,
                "text": "The Trust is committed to the provision of a service that is fair, accessible and meets the needs of all individuals."
            },
            "type": "ListItem",
            "sequence_num": 252
        },
        {
            "data": {
                "is_heading": 0,
                "text": "(Refer to appendix 3)"
            },
            "type": "ListItem",
            "sequence_num": 253
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 23.0,
                "text": "References"
            },
            "type": "ListItem",
            "sequence_num": 254
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 2.0,
                "text": "UK policy framework for health and social care research  Health Research Authority"
            },
            "type": "ListItem",
            "sequence_num": 255
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 4.0,
                "text": "Best Research for Best Health  HRA Approval"
            },
            "type": "ListItem",
            "sequence_num": 256
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 5.0,
                "text": "Research Ethics Service"
            },
            "type": "ListItem",
            "sequence_num": 257
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 6.0,
                "text": "Clinicaltrials.gov"
            },
            "type": "ListItem",
            "sequence_num": 258
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 7.0,
                "text": "Human Tissue Act 2004"
            },
            "type": "ListItem",
            "sequence_num": 259
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 8.0,
                "text": "Attributing the Costs of Health and Social Care Research"
            },
            "type": "ListItem",
            "sequence_num": 260
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 9.0,
                "text": "NIHR Industry Costing Template"
            },
            "type": "ListItem",
            "sequence_num": 261
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 10.0,
                "text": "Data Protection Act 2018 (legislation.gov.uk)"
            },
            "type": "ListItem",
            "sequence_num": 262
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 11.0,
                "text": "GDPR"
            },
            "type": "ListItem",
            "sequence_num": 263
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 12.0,
                "text": "MSEFT Information Governance & Management Policy"
            },
            "type": "ListItem",
            "sequence_num": 264
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 13.0,
                "text": "MSEFT Information Governance Handbook"
            },
            "type": "ListItem",
            "sequence_num": 265
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 14.0,
                "text": "MSEFT National Data Opt Out Policy"
            },
            "type": "ListItem",
            "sequence_num": 266
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 16.0,
                "text": "The Medicines for Human Use (Clinical Trials) (2004) regulations   NIHR Model Clinical Trial Agreements"
            },
            "type": "ListItem",
            "sequence_num": 267
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 17.0,
                "text": "Organisational Information Document (OID)"
            },
            "type": "ListItem",
            "sequence_num": 268
        },
        {
            "data": {
                "is_heading": 0,
                "prefix": 18.0,
                "text": "NHS Honorary Contract, Letter of Access and Research Passports"
            },
            "type": "ListItem",
            "sequence_num": 269
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 1: Principles that apply to all health and social care research"
            },
            "type": "ListItem",
            "sequence_num": 270
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The following statement of principles serves as a benchmark for good practice that the management and conduct of all health and social care research in the UK are expected to meet."
            },
            "type": "ListItem",
            "sequence_num": 271
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principle 1: Safety"
            },
            "type": "ListItem",
            "sequence_num": 272
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The safety and well-being of the individual prevail over the interests of science and society."
            },
            "type": "ListItem",
            "sequence_num": 273
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principle 2: Competence"
            },
            "type": "ListItem",
            "sequence_num": 274
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All the people involved in managing and conducting a research project are qualified by education, training and experience, or otherwise competent under the supervision of a suitably qualified person, to perform their tasks."
            },
            "type": "ListItem",
            "sequence_num": 275
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principle 3: Scientific and Ethical Conduct"
            },
            "type": "ListItem",
            "sequence_num": 276
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Research projects are scientifically sound and guided by ethical principles in all their aspects."
            },
            "type": "ListItem",
            "sequence_num": 277
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principle 4: Patient, Service User and Public Involvement"
            },
            "type": "ListItem",
            "sequence_num": 278
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Patients, service users and the public are involved in the design, management, conduct and dissemination of research, unless otherwise justified."
            },
            "type": "ListItem",
            "sequence_num": 279
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principle 5: Integrity, Quality and Transparency"
            },
            "type": "ListItem",
            "sequence_num": 280
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Research is designed, reviewed, managed and undertaken in a way that ensures integrity, quality and transparency."
            },
            "type": "ListItem",
            "sequence_num": 281
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principle 6: Protocol"
            },
            "type": "ListItem",
            "sequence_num": 282
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The design and procedure of the research are clearly described and justified in a research proposal or protocol, where applicable conforming to a standard template and/or specified contents."
            },
            "type": "ListItem",
            "sequence_num": 283
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principle 7: Legality"
            },
            "type": "ListItem",
            "sequence_num": 284
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The researchers and sponsor familiarise themselves with relevant legislation and guidance in respect of managing and conducting the research."
            },
            "type": "ListItem",
            "sequence_num": 285
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principle 8: Benefits and Risks"
            },
            "type": "ListItem",
            "sequence_num": 286
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Before the research project is started, any anticipated benefit for the individual participant and other present and future recipients of the health or social care in question is weighed against the foreseeable risks and inconveniences once they have been mitigated."
            },
            "type": "ListItem",
            "sequence_num": 287
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principle 9: Approval"
            },
            "type": "ListItem",
            "sequence_num": 288
        },
        {
            "data": {
                "is_heading": 0,
                "text": "A research project is started only if a research ethics committee and any other relevant approval body have favourably reviewed the research proposal or protocol and related information, where their review is expected or required."
            },
            "type": "ListItem",
            "sequence_num": 289
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principle 10: Information about the Research"
            },
            "type": "ListItem",
            "sequence_num": 290
        },
        {
            "data": {
                "is_heading": 0,
                "text": "In order to avoid waste, information about research projects (other than those for educational purposes) is made publicly available before they start (unless a deferral is agreed by or on behalf of the research ethics committee)."
            },
            "type": "ListItem",
            "sequence_num": 291
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principle 11: Accessible Findings"
            },
            "type": "ListItem",
            "sequence_num": 292
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Other than research for educational purposes and early phase trials, the findings, whether positive or negative, are made accessible, with adequate consent and privacy safeguards, in a timely manner after they have finished, in compliance with any applicable regulatory standards, i.e. legal requirements or expectations of regulators. In addition, where appropriate, information about the findings of the research is available, in a suitable format and timely manner, to those who took part in it, unless otherwise justified."
            },
            "type": "ListItem",
            "sequence_num": 293
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principle 12: Choice"
            },
            "type": "ListItem",
            "sequence_num": 294
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Research participants are afforded respect and autonomy, taking account of their capacity to understand. Where there is a difference between the research and the standard practice that they might otherwise experience, research participants are given information to understand the distinction and make a choice, unless a research ethics committee agrees otherwise. Where participants' explicit consent is sought, it is voluntary and informed. Where consent is refused or withdrawn, this is done without reprisal."
            },
            "type": "ListItem",
            "sequence_num": 295
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principle 13: Insurance and Indemnity"
            },
            "type": "ListItem",
            "sequence_num": 296
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Adequate provision is made for insurance or indemnity to cover liabilities which may arise in relation to the design, management and conduct of the research project."
            },
            "type": "ListItem",
            "sequence_num": 297
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principle 14: Respect for Privacy"
            },
            "type": "ListItem",
            "sequence_num": 298
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All information collected for or as part of the research project is recorded, handled and stored appropriately and in such a way and for such time that it can be accurately reported, interpreted and verified, while the confidentiality of individual research participants remains appropriately protected. Data and tissue collections are managed in a transparent way that demonstrates commitment to their appropriate use for research and appropriate protection of privacy."
            },
            "type": "ListItem",
            "sequence_num": 299
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principle 15: Compliance"
            },
            "type": "ListItem",
            "sequence_num": 300
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Sanctions for non-compliance with these principles may include appropriate and proportionate administrative, contractual or legal measures by funders, employers, relevant professional and statutory regulators, and other bodies."
            },
            "type": "ListItem",
            "sequence_num": 301
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principles that apply to interventional health and social care research"
            },
            "type": "ListItem",
            "sequence_num": 302
        },
        {
            "data": {
                "is_heading": 0,
                "text": "In addition to the principles above, the following principles apply to interventional research only, i.e. where a change in treatment, care or other services is made for the purpose of research:"
            },
            "type": "ListItem",
            "sequence_num": 303
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principle 16: Justified Intervention"
            },
            "type": "ListItem",
            "sequence_num": 304
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The intended deviation from normal treatment, care or other services is adequately supported by the available information (including evidence from previous research)."
            },
            "type": "ListItem",
            "sequence_num": 305
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principle 17: Ongoing Provision of Treatment"
            },
            "type": "ListItem",
            "sequence_num": 306
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The research proposal or protocol and the participant information sheet explain the special arrangements, if any, after the research intervention period has ended (e.g. continuing or changing the treatment, care or other services that were introduced for the purposes of the research)."
            },
            "type": "ListItem",
            "sequence_num": 307
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principle 18: Integrity of the Care Record"
            },
            "type": "ListItem",
            "sequence_num": 308
        },
        {
            "data": {
                "is_heading": 0,
                "text": "All information about treatment, care or other services provided as part of the research project and their outcomes is recorded, handled and stored appropriately and in such a way and for such time that it can be understood, where relevant, by others involved in the participant's care and accurately reported, interpreted and verified, while the confidentiality of records of the participants remains protected."
            },
            "type": "ListItem",
            "sequence_num": 309
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Principle 19: Duty of Care"
            },
            "type": "ListItem",
            "sequence_num": 310
        },
        {
            "data": {
                "is_heading": 0,
                "text": "The duty of care owed by health and social care providers continues to apply when their patients and service users take part in research. A relevant health or social care professional retains responsibility for the treatment, care or other services given to patients and service users as research participants and for decisions about their treatment, care or other services. If an unmanageable conflict arises between research and patient interests, the duty to the participant as a patient prevails."
            },
            "type": "ListItem",
            "sequence_num": 311
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 2: Responsibilities framework"
            },
            "type": "ListItem",
            "sequence_num": 312
        },
        {
            "type": "table",
            "sequence_num": 313,
            "data": {
                "num_rows": 15,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": "Principle"
                    },
                    {
                        "text": "Responsibility of"
                    },
                    {
                        "text": "Responsibility covered"
                    },
                    {
                        "text": "Evidence/activity"
                    },
                    {
                        "text": "R&D"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "CI"
                    },
                    {
                        "text": "9.2a, i"
                    },
                    {
                        "text": "Peer review, ethics, HRA approval, R&D SOPs"
                    },
                    {
                        "text": "Assess, Arrange, Confirm (AAC)"
                    },
                    {
                        "text": "Research Teams"
                    },
                    {
                        "text": "9.6e"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Quality Management System (QMS)"
                    },
                    {
                        "text": "Sponsor"
                    },
                    {
                        "text": "9.10a, g, i"
                    },
                    {
                        "text": "Peer review"
                    },
                    {
                        "text": "Where Trust is the sponsor, R&D SOPs"
                    },
                    {
                        "text": "Employers"
                    },
                    {
                        "text": "9.20a, 9.22"
                    },
                    {
                        "text": "R&D polices and SOPs"
                    },
                    {
                        "text": "Annual report, R&D Strategy, QMS"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "CI"
                    },
                    {
                        "text": "9.2d"
                    },
                    {
                        "text": "GCP, CV, R&D SOP 06"
                    },
                    {
                        "text": "QMS"
                    },
                    {
                        "text": "Research Teams"
                    },
                    {
                        "text": "9.6a, b"
                    },
                    {
                        "text": "GCP, CV, R&D SOP 06"
                    },
                    {
                        "text": "QMS"
                    },
                    {
                        "text": "Sponsor"
                    },
                    {
                        "text": "9.10b, h"
                    },
                    {
                        "text": "CV, GCP, AAC"
                    },
                    {
                        "text": "Where Trust is the sponsor, QMS"
                    },
                    {
                        "text": "Research Site"
                    },
                    {
                        "text": "9.16d"
                    },
                    {
                        "text": "AAC"
                    },
                    {
                        "text": "QMS"
                    },
                    {
                        "text": "Employers"
                    },
                    {
                        "text": "9.20c, 9.21"
                    },
                    {
                        "text": "GCP/CV, AAC, R&D SOP 06"
                    },
                    {
                        "text": "QMS"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "CI"
                    },
                    {
                        "text": "9.2a, b, c, 9.3, 9.4, 9.5"
                    },
                    {
                        "text": "Peer review, ethics and HRA approval AAC, R&D Management Policy and SOP13"
                    },
                    {
                        "text": "Where Trust is the sponsor QMS"
                    },
                    {
                        "text": "Funder"
                    },
                    {
                        "text": "9.9a"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "For pilot studies in preparation for grant applications"
                    },
                    {
                        "text": "Sponsor"
                    },
                    {
                        "text": "9.10a, f"
                    },
                    {
                        "text": "Ethics. HRA"
                    },
                    {
                        "text": "Where Trust is the sponsor QMS"
                    },
                    {
                        "text": "Research Site"
                    },
                    {
                        "text": "9.14d, 9.16d"
                    },
                    {
                        "text": "Ethics, HRA AAC"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Regulators (professions and other)"
                    },
                    {
                        "text": "9.18"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 314,
            "data": {
                "num_rows": 16,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": "Principle"
                    },
                    {
                        "text": "Responsibility of"
                    },
                    {
                        "text": "Responsibility covered"
                    },
                    {
                        "text": "Evidence/activity"
                    },
                    {
                        "text": "R&D"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Employer"
                    },
                    {
                        "text": "9.20b"
                    },
                    {
                        "text": "AAC, R&D Management Policy and SOP 13"
                    },
                    {
                        "text": "QMS"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "CI"
                    },
                    {
                        "text": "9.2, 9.3b, 9.4"
                    },
                    {
                        "text": "Ethics, R&D Management Policy and SOP 13"
                    },
                    {
                        "text": "Where Trust is the sponsor"
                    },
                    {
                        "text": "Funder"
                    },
                    {
                        "text": "9.9a"
                    },
                    {
                        "text": "Peer review, ethics"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Sponsor"
                    },
                    {
                        "text": "9.10a"
                    },
                    {
                        "text": "Peer review, ethics"
                    },
                    {
                        "text": "Where Trust is the sponsor"
                    },
                    {
                        "text": "Health & Social Care Provider"
                    },
                    {
                        "text": "9.9a"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "CI"
                    },
                    {
                        "text": "9.4, 9.5"
                    },
                    {
                        "text": "Peer review, ethics, HRA"
                    },
                    {
                        "text": "Where Trust is the sponsor"
                    },
                    {
                        "text": "Research Team"
                    },
                    {
                        "text": "9.6, 9.6c, 9.7c"
                    },
                    {
                        "text": "R&D SOP 06, 07, 14, 19"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Funder"
                    },
                    {
                        "text": "9.9a"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Sponsor"
                    },
                    {
                        "text": "9.10a, c, 9.13"
                    },
                    {
                        "text": "Peer review, ethics"
                    },
                    {
                        "text": "Where Trust is the sponsor"
                    },
                    {
                        "text": "Research Site"
                    },
                    {
                        "text": "9.14b, c, 9.16a, f"
                    },
                    {
                        "text": "R&D Strategy, Policies and SOPs, AAC"
                    },
                    {
                        "text": "QMS"
                    },
                    {
                        "text": "Employer"
                    },
                    {
                        "text": "9.20a, d, 9.22"
                    },
                    {
                        "text": "R&D Strategy, Policies and SOPs"
                    },
                    {
                        "text": "QMS"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Ci"
                    },
                    {
                        "text": "9.2a, b, I, 9.4, 9.5"
                    },
                    {
                        "text": "Peer review, ethics, HRA, AAC R&D SOP 03, 19"
                    },
                    {
                        "text": "Where Trust is the sponsor"
                    },
                    {
                        "text": "Research Team"
                    },
                    {
                        "text": "9.6c"
                    },
                    {
                        "text": "R&D SOP 13, 19"
                    },
                    {
                        "text": "QMS"
                    },
                    {
                        "text": "Sponsor"
                    },
                    {
                        "text": "9.10a, i"
                    },
                    {
                        "text": "Peer review, ethics, HRA, R&D SOP 03, 05, 13"
                    },
                    {
                        "text": "Where Trust is the sponsor"
                    },
                    {
                        "text": "Regulators (professions and other)"
                    },
                    {
                        "text": "9.15"
                    },
                    {
                        "text": "HRA approval"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 315,
            "data": {
                "num_rows": 13,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": "Principle"
                    },
                    {
                        "text": "Responsibility of"
                    },
                    {
                        "text": "Responsibility covered"
                    },
                    {
                        "text": "Evidence/activity"
                    },
                    {
                        "text": "R&D"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "CI"
                    },
                    {
                        "text": "9.2a"
                    },
                    {
                        "text": "Peer review, ethics, HRA approval R&D SOPs"
                    },
                    {
                        "text": "Where Trust is the sponsor"
                    },
                    {
                        "text": "Research Team"
                    },
                    {
                        "text": "9.8"
                    },
                    {
                        "text": "R&D SOPs"
                    },
                    {
                        "text": "QMS"
                    },
                    {
                        "text": "Sponsor"
                    },
                    {
                        "text": "9.10a, 9.11"
                    },
                    {
                        "text": "Peer review"
                    },
                    {
                        "text": "Where Trust is the sponsor, R&D SOPs"
                    },
                    {
                        "text": "Research Site"
                    },
                    {
                        "text": "9.15, 9.16d"
                    },
                    {
                        "text": "AAC"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Regulators (professions and other)"
                    },
                    {
                        "text": "9.15, 9.18"
                    },
                    {
                        "text": "AAC, R&D SOPs"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Health & Social Care Provider"
                    },
                    {
                        "text": "9.23c"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "CI"
                    },
                    {
                        "text": "9.3a, 9.4"
                    },
                    {
                        "text": "Peer review, ethics, R&D SOP 24"
                    },
                    {
                        "text": "Where Trust is the sponsor"
                    },
                    {
                        "text": "Research Team"
                    },
                    {
                        "text": "9.8"
                    },
                    {
                        "text": "AAC, feasibility, R&D Working Documents"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Sponsor"
                    },
                    {
                        "text": "9.10h"
                    },
                    {
                        "text": "R&D SOP 24"
                    },
                    {
                        "text": "Where Trust is the sponsor"
                    },
                    {
                        "text": "Research Site"
                    },
                    {
                        "text": "9.15"
                    },
                    {
                        "text": "AAC, R&D SOP 24"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Regulators (professions and other)"
                    },
                    {
                        "text": "9.18"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Employer"
                    },
                    {
                        "text": "9.21"
                    },
                    {
                        "text": "R&D Policies, SOPs and Working Documents"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 316,
            "data": {
                "num_rows": 9,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": "Principle"
                    },
                    {
                        "text": "Responsibility of"
                    },
                    {
                        "text": "Responsibility covered"
                    },
                    {
                        "text": "Evidence/activity"
                    },
                    {
                        "text": "R&D"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "CI"
                    },
                    {
                        "text": "9.2c, 9.5"
                    },
                    {
                        "text": "Ethics, HRA, Research Management Policy"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Funder"
                    },
                    {
                        "text": "9.9d"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Sponsor"
                    },
                    {
                        "text": "9.10f"
                    },
                    {
                        "text": "Ethics, HRA, AAC"
                    },
                    {
                        "text": "Where Trust is the sponsor"
                    },
                    {
                        "text": "Research Site"
                    },
                    {
                        "text": "9.14d"
                    },
                    {
                        "text": "AAC, R&D SOPs, Working Documents"
                    },
                    {
                        "text": "Governance Policy"
                    },
                    {
                        "text": "Regulators (professions and other)"
                    },
                    {
                        "text": "9.18"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "CI"
                    },
                    {
                        "text": "9.2f"
                    },
                    {
                        "text": "Research Management Policy and SOPs"
                    },
                    {
                        "text": "Where Trust is the sponsor"
                    },
                    {
                        "text": "Funder"
                    },
                    {
                        "text": "9.9e"
                    },
                    {
                        "text": "AAC"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Sponsor"
                    },
                    {
                        "text": "9.10e"
                    },
                    {
                        "text": "Clinicaltrials.gov"
                    },
                    {
                        "text": "Where Trust is the sponsor"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 317,
            "data": {
                "num_rows": 6,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": "Principle"
                    },
                    {
                        "text": "Responsibility of"
                    },
                    {
                        "text": "Responsibility covered"
                    },
                    {
                        "text": "Evidence/activity"
                    },
                    {
                        "text": "R&D"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "CI"
                    },
                    {
                        "text": "9.2j"
                    },
                    {
                        "text": "Research Management Policy, SOP 28"
                    },
                    {
                        "text": "Where Trust is the sponsor"
                    },
                    {
                        "text": "Funder"
                    },
                    {
                        "text": "9.9e"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Sponsor"
                    },
                    {
                        "text": "9.10e"
                    },
                    {
                        "text": "Research Management Policy, SOP 28"
                    },
                    {
                        "text": "Where Trust is the sponsor"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "CI"
                    },
                    {
                        "text": "9.2e"
                    },
                    {
                        "text": "R&D SOP 03,19"
                    },
                    {
                        "text": "Where Trust is the sponsor"
                    },
                    {
                        "text": "Research Team"
                    },
                    {
                        "text": "9.6d, 9.7a, 9.8"
                    },
                    {
                        "text": "R&D SOP 3, 19"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 318,
            "data": {
                "num_rows": 7,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": "Principle"
                    },
                    {
                        "text": "Responsibility of"
                    },
                    {
                        "text": "Responsibility covered"
                    },
                    {
                        "text": "Evidence/activity"
                    },
                    {
                        "text": "R&D"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Sponsor"
                    },
                    {
                        "text": "9.10d, h"
                    },
                    {
                        "text": "Research Management Policy, SOPs"
                    },
                    {
                        "text": "Where Trust is the sponsor"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "CI"
                    },
                    {
                        "text": "9.2g"
                    },
                    {
                        "text": "Research Management Policy, HRA , AAC, R&D SOPs"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Funder"
                    },
                    {
                        "text": "9.9e"
                    },
                    {
                        "text": "HRA, AAC"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Sponsor"
                    },
                    {
                        "text": "9.10e"
                    },
                    {
                        "text": "Clinicaltrials.gov, Research Management Policy and SOPs"
                    },
                    {
                        "text": "Where Trust is the sponsor"
                    },
                    {
                        "text": "Research Site"
                    },
                    {
                        "text": "9.14d"
                    },
                    {
                        "text": "Research Management Policy, Trust Asset Register"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Regulators (professions and other)"
                    },
                    {
                        "text": "9.16d"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 319,
            "data": {
                "num_rows": 8,
                "num_cols": 4,
                "table_items": [
                    {
                        "text": "Principle"
                    },
                    {
                        "text": "Responsibility of"
                    },
                    {
                        "text": "Responsibility covered"
                    },
                    {
                        "text": "Evidence/activity"
                    },
                    {
                        "text": "R&D"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "CI"
                    },
                    {
                        "text": "9.2a, i"
                    },
                    {
                        "text": "R&D Policies, SOP 11"
                    },
                    {
                        "text": "Where Trust is the sponsor"
                    },
                    {
                        "text": "Research Team"
                    },
                    {
                        "text": "9.6c, 9.8"
                    },
                    {
                        "text": "R&D SOP 11"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Funder"
                    },
                    {
                        "text": "9.9e"
                    },
                    {
                        "text": "HRA, AAC"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Sponsor"
                    },
                    {
                        "text": "9.10a, I, 9.11"
                    },
                    {
                        "text": "R&D Policies"
                    },
                    {
                        "text": "Where Trust is the sponsor"
                    },
                    {
                        "text": "Research Site"
                    },
                    {
                        "text": "9.15, 9.16d"
                    },
                    {
                        "text": "AAC"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Regulators (professions and other)"
                    },
                    {
                        "text": "9.15, 9.16d, 9.17"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "Employer"
                    },
                    {
                        "text": "9.20a, b, d, 9.21, 9.22"
                    },
                    {
                        "text": "R&D Strategy, AAC"
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Research management policy / MSEPO-21077 / 1.0"
            },
            "type": "ListItem",
            "sequence_num": 320
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 37.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 321
        },
        {
            "data": {
                "is_heading": 0,
                "text": "Research management policy / MSEPO-21077 / 1.0"
            },
            "type": "ListItem",
            "sequence_num": 322
        },
        {
            "data": {
                "is_heading": 1,
                "text": "Appendix 3: Preliminary equality analysis"
            },
            "type": "ListItem",
            "sequence_num": 323
        },
        {
            "data": {
                "is_heading": 1,
                "text": "This assessment relates to: Research management policy/MSEPO-21077 (please tick all that apply)"
            },
            "type": "ListItem",
            "sequence_num": 324
        },
        {
            "type": "table",
            "sequence_num": 325,
            "data": {
                "num_rows": 3,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "\u2610 A change in a service to patients"
                    },
                    {
                        "text": "\u2610 A change to an existing document"
                    },
                    {
                        "text": "\u2610 A change to the way staff work"
                    },
                    {
                        "text": "\u2610 A new document"
                    },
                    {
                        "text": "\u2610 Something else (please give details)"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": ""
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 326,
            "data": {
                "num_rows": 7,
                "num_cols": 2,
                "table_items": [
                    {
                        "text": "Questions"
                    },
                    {
                        "text": "Answers"
                    },
                    {
                        "text": "1."
                    },
                    {
                        "text": "What are you proposing to change?"
                    },
                    {
                        "text": "New MSE document"
                    },
                    {
                        "text": "2."
                    },
                    {
                        "text": "Why are you making this change? (What will the change achieve?)"
                    },
                    {
                        "text": "MSE standardisation"
                    },
                    {
                        "text": "3."
                    },
                    {
                        "text": "Who benefits from this change and how?"
                    },
                    {
                        "text": "Staff and patients"
                    },
                    {
                        "text": "4."
                    },
                    {
                        "text": "Is anyone likely to suffer any negative impact as a result of this change? If no, please record reasons here and sign and date this assessment. If yes, please complete a full EIA."
                    },
                    {
                        "text": "No"
                    },
                    {
                        "text": "5."
                    },
                    {
                        "text": "a) Will you be undertaking any consultation as part of this change?"
                    },
                    {
                        "text": "Yes"
                    },
                    {
                        "text": ""
                    },
                    {
                        "text": "b) If so, with whom?"
                    },
                    {
                        "text": "Refer to pages 1 & 2"
                    }
                ]
            }
        },
        {
            "type": "table",
            "sequence_num": 327,
            "data": {
                "num_rows": 2,
                "num_cols": 3,
                "table_items": [
                    {
                        "text": "Preliminary analysis completed by:"
                    },
                    {
                        "text": "Name"
                    },
                    {
                        "text": "Ashley Solieri"
                    },
                    {
                        "text": "Job Title"
                    },
                    {
                        "text": "Group Head of Research"
                    },
                    {
                        "text": "March 2021"
                    }
                ]
            }
        },
        {
            "data": {
                "is_heading": 1,
                "prefix": 35.0,
                "text": "Page  of"
            },
            "type": "ListItem",
            "sequence_num": 328
        }
    ]
}